Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Hemangioma, Capillary 3Vascular Malformations 1Recurrence 1Port-Wine Stain 1Papilloma 1Keratosis, Actinic 1Hemangioma 1

Interventions

Timolol 7Propranolol 7Lasers, Dye 3Population Groups 2Nadolol 2Imiquimod 2Atenolol 2ziprasidone 1propranolol mustard 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Ultrasonography 1Tranexamic Acid 1Tobramycin 1Surgery, Computer-Assisted 1Spironolactone 1Sevelamer 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Ophthalmic Solutions 1Ointments 1Nifedipine 1Nafcillin 1Mupirocin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hemangioma, Capillary × Lasers, Dye × Clear all
NCT01873131 2023-11-02

A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

Massachusetts General Hospital

Phase NA Recruiting
126 enrolled

Hemangioma, Hemangioma, Capillary

NCT00573729 2022-10-20

Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths

University of California, Irvine

Phase 1 Completed
56 enrolled

Hemangioma, Capillary, Vascular Malformations

NCT00365118 2008-06-03

Treatment of Naevus Flammeus Using Intense Pulsed Light and Pulsed Dye Laser

Bispebjerg Hospital

Phase NA Completed

Hemangioma, Capillary, Port-Wine Stain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡